An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX ® in Patients With Hemophilia B
Condition:   Hemophilia B Interventions:   Genetic: HEMGENIX;   Biological: Factor IX (FIX) Sponsor:   CSL Behring Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials